# China Lung Cancer Screening (CLUS) Study Version 3.0

> **NCT05494021** · NA · RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 100000 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** Whole-process management software
- **DEVICE:** LDCT detection

## Key facts

- **NCT ID:** NCT05494021
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494021, "China Lung Cancer Screening (CLUS) Study Version 3.0". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05494021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*